Is ANIP Overvalued?

ANIP is now in the Fair zone, suggesting that ANIP current forward PE ratio of 10.21 is considered Fair compare with the five-year average of 12.47.
P/E
EV/EBITDA
P/S
P/B
bubble
P/E

ANIP Competitors Valuation Multiple

P/E
EV/EBITDA
P/S

P/E Multiple

Earnings Growth
Market Cap
stocks logo
ANIP.O
ANI Pharmaceuticals Inc
10.21
Average P/E: 10.21
-1612.78%
1.38B
stocks logo
NVAX.O
Novavax Inc
loss
64.88%
1.30B
stocks logo
GPCR.O
Structure Therapeutics Inc
loss
-20.34%
1.23B
stocks logo
CLDX.O
Celldex Therapeutics Inc
loss
1.41B
stocks logo
ARVN.O
Arvinas Inc
loss
75.24%
621.01M
stocks logo
DYN.O
Dyne Therapeutics Inc
loss
19.13%
1.40B

ANIP Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

ANIP FAQs

Is ANIP currently overvalued based on its P/E ratio?

According to the provided data, ANIP's 5-year historical average forward P/E ratio is 12.47. ANIP forward P/E ratio is 10.21, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for ANIP?

How has ANIP's Price to Sales (PS) ratio evolved?

What are the key indicators to watch for ANIP's financial performance?

ANIP PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Fair
5Y Average PE
12.47
Current PE
10.21
Overvalued PE
16.79
Undervalued PE
8.15

ANIP EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Fair
5Y Average EV
9.27
Current EV
9.01
Overvalued EV
11.14
Undervalued EV
7.41

ANIP P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Fair
5Y Average PS
1.87
Current PS
1.62
Overvalued PS
2.19
Undervalued PS
1.55

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is ANIP undervalued?Is ANIP overvalued compared to its competitors?